• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • PROs
    • Menopause Rating Scale
      • Menopause Rating Scale (MRS) – Languages
    • Aging Male Symptoms Scale
      • AMS – properties as an outcome measure
      • AMS – properties as a screening tool
    • Quality of Sexual Function Scale
      • Quality of Sexual Function Scale
    • Short Term Hormone Effect Scale
      • Short Term Hormone Effect Scale
    • Research team
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Menopause Rating Scale (MRS) – Languages

An international scale for all women

All known MRS versions are available below in PDF-format (Adobe Acrobat). As most translations followed recognised methodology for language adaptation, we assume that the translations have linguistic and cultural equivalence.

Researchers interested in using the MRS for non-commercial purposes please contact us (ratingscales@zeg-berlin.de)and inform about your intentions for use of the MRS. After granting non-commercial use, the requested MRS will be provided in PDF format.

For licensing the MRS for commercial purposes please contact us (ratingscales@zeg-berlin.de).

If the scale is applied to countries with the “same” language, e.g. Spain and Mexico, United Kingdom and the United States, a critical review of the translation should be conducted in order to ensure cultural as well as linguistic equivalence. In some cases, a new translation may be necessary.

The following languages are currently available for use:

  • Belgium-Dutch version
  • Belgium-French version
  • Bulgarian version
  • Chilean version1
  • Chinese – Mainland version2
  • Chinese – Taiwan version
  • Croatian version
  • Danish version
  • Dutch version!
  • English – UK version
  • English – US version
  • Finish version
  • French version
  • German version
  • Greece version
  • Indonesian version3
  • Italian version
  • Japanese version
  • Korean version
  • Mexican/Argentinian version
  • Polish version
  • Portuguese (Brazil) version!
  • Portuguese (Portugal) version!4
  • Romanian version
  • Russian version
  • South African-Afrikaans version
  • South African-English version
  • Spanish version
  • Swedish version
  • Tagalog version
  • Turkish version
  • Ukrainian (Russ.) version
  • Ukrainian (Ukrain.) version

1. Aedo M, S; Porcile J, A; Irribarra A, C (2006) Calidad De Vida Relacionada Con El Climaterio En Una Población Chilena De Mujeres Saludables. In : Revista chilena de obstetricia y ginecología, vol. 71, n° 6. DOI: 10.4067/S0717-75262006000600007.

2. Wu, HC; Wen, SH; Hwang, JS; Huang, SC (2015) Validation of the traditional Chinese version of the Menopausal Rating Scale with WHOQOL-BREF. In : Climacteric: the journal of the International Menopause Society, vol. 18, n° 5, p. 750–756. DOI: 10.3109/13697137.2015.1044513.

3. Dwi Susanti, H; Chang, PC; Chung, MH (2019) Construct validity of the Menopause Rating Scale in Indonesia. In : Climacteric: the journal of the International Menopause Society, vol. 22, n° 5, p. 454–459. DOI: 10.1080/13697137.2019.1574737.

4. Espírito Santo, J; Marques de Loureiro, NE; Brandão-Loureiro, V; Aibar-Almazán, A; Hita-Contreras, F (2023) Psychometric properties and validity of the Menopause Rating Scale in postmenopausal Portuguese women. In : Menopause (New York, N.Y.), vol. 30, n° 2, p. 179–185. DOI: 10.1097/GME.0000000000002104.

sidebar

Expertise

  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Patient Reported Outcomes (PROs)
    • Aging Male Symptoms Scale
    • Menopause Rating Scale
    • Scale for Quality of Sexual Function
    • Short Term Hormone Effect Scale
    • Research team
  • Data collection instruments

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Patient Reported Outcomes (PROs)
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2025 ZEG Berlin

Impressum

Website by Laura Yeffeth.